These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 24295076)

  • 1. The impact of iodinated contrast agent administered during preoperative computed tomography scan on body iodine pool in patients with differentiated thyroid cancer preparing for radioactive iodine treatment.
    Sohn SY; Choi JH; Kim NK; Joung JY; Cho YY; Park SM; Kim TH; Jin SM; Bae JC; Lee SY; Chung JH; Kim SW
    Thyroid; 2014 May; 24(5):872-7. PubMed ID: 24295076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Iodinated Contrast-enhanced CT on Urinary Iodine Levels in Postoperative Patients with Differentiated Thyroid Cancer.
    Fang S; Han S; Zhang P; Zhao C
    Curr Med Imaging; 2024; 20():e15734056287560. PubMed ID: 39185655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One month is sufficient for urinary iodine to return to its baseline value after the use of water-soluble iodinated contrast agents in post-thyroidectomy patients requiring radioiodine therapy.
    Padovani RP; Kasamatsu TS; Nakabashi CC; Camacho CP; Andreoni DM; Malouf EZ; Marone MM; Maciel RM; Biscolla RP
    Thyroid; 2012 Sep; 22(9):926-30. PubMed ID: 22827435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between excessive urinary iodine excretion and failure of radioactive iodine thyroid ablation in patients with papillary thyroid cancer.
    Sohn SY; Choi JY; Jang HW; Kim HJ; Jin SM; Kim SW; Suh S; Hur KY; Kim JH; Chung JH; Kim SW
    Thyroid; 2013 Jun; 23(6):741-7. PubMed ID: 23205883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative contrast-enhanced computerized tomography should not delay radioiodine ablation in differentiated thyroid carcinoma patients.
    Mishra A; Pradhan PK; Gambhir S; Sabaretnam M; Gupta A; Babu S
    J Surg Res; 2015 Feb; 193(2):731-7. PubMed ID: 25193578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of body iodine pool assessment methods before radioiodine therapy.
    Genc M; Yildirim A; Yildirim N
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2024; 43(2):107-112. PubMed ID: 38331249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low iodine diet for one week is sufficient for adequate preparation of high dose radioactive iodine ablation therapy of differentiated thyroid cancer patients in iodine-rich areas.
    Lee M; Lee YK; Jeon TJ; Chang HS; Kim BW; Lee YS; Park CS; Ryu YH
    Thyroid; 2014 Aug; 24(8):1289-96. PubMed ID: 24731156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daily urine iodine excretion while consuming a low-iodine diet in preparation for radioactive iodine therapy in a high iodine intake area.
    Kim HK; Lee SY; Lee JI; Jang HW; Kim SK; Chung HS; Tan AH; Hur KY; Kim JH; Chung JH; Kim SW
    Clin Endocrinol (Oxf); 2011 Dec; 75(6):851-6. PubMed ID: 21707689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexpected effect of furosemide on radioiodine urinary excretion in patients with differentiated thyroid carcinomas treated with iodine 131.
    Matovic MD; Jankovic SM; Jeremic M; Tasic Z; Vlajkovic M
    Thyroid; 2009 Aug; 19(8):843-8. PubMed ID: 19519221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of the new American Thyroid Association guidelines leads to a substantial rate of completion total thyroidectomy to enable adjuvant radioactive iodine.
    Kluijfhout WP; Pasternak JD; Drake FT; Beninato T; Shen WT; Gosnell JE; Suh I; C L; Duh QY
    Surgery; 2017 Jan; 161(1):127-133. PubMed ID: 27855968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern of urine iodine excretion with low iodine diet during preparation for radioactive iodine ablation in patients with thyroid cancer.
    Kang SW; Yap ZZ; Lee CR; Lee J; Jeong JJ; Nam KH; Yun MJ; Lee EJ; Chung WY; Park CS
    Head Neck; 2019 Feb; 41(2):381-387. PubMed ID: 30548084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Papillary thyroid carcinoma arising from a thyroglossal duct cyst: a single institution experience.
    Choi YM; Kim TY; Song DE; Hong SJ; Jang EK; Jeon MJ; Han JM; Kim WG; Shong YK; Kim WB
    Endocr J; 2013; 60(5):665-70. PubMed ID: 23318645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Pregnancy Outcomes and Radioactive Iodine Treatment After Thyroidectomy Among Women With Thyroid Cancer.
    Kim HO; Lee K; Lee SM; Seo GH
    JAMA Intern Med; 2020 Jan; 180(1):54-61. PubMed ID: 31633736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Influencing the Success of the First Radioiodine Therapy for Differentiated Thyroid Carcinoma.
    Claimon A; Pusuwan P; Khiewvan B
    J Med Assoc Thai; 2017 Feb; 100(2):207-18. PubMed ID: 29916638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The results of selective use of radioactive iodine on survival and on recurrence in the management of papillary thyroid cancer, based on Memorial Sloan-Kettering Cancer Center risk group stratification.
    Nixon IJ; Ganly I; Patel SG; Palmer FL; Di Lorenzo MM; Grewal RK; Larson SM; Tuttle RM; Shaha A; Shah JP
    Thyroid; 2013 Jun; 23(6):683-94. PubMed ID: 23742290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of Radioactive Iodine Administration Does Not Influence Outcomes in Patients with Differentiated Thyroid Carcinoma.
    Scheffel RS; Zanella AB; Dora JM; Maia AL
    Thyroid; 2016 Nov; 26(11):1623-1629. PubMed ID: 27549175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiated thyroid carcinoma: Incremental diagnostic value of
    Zilioli V; Peli A; Panarotto MB; Magri G; Alkraisheh A; Wiefels C; Rodella C; Giubbini R
    Endocrine; 2017 Jun; 56(3):551-559. PubMed ID: 27709475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium as an adjuvant in the postoperative ablation of remnant tissue in low-risk thyroid carcinoma.
    Yamazaki CA; Padovani RP; Biscolla RP; Ikejiri ES; Marchetti RR; Castiglioni ML; Matsumura LK; Maciel RM; Furlanetto RP
    Thyroid; 2012 Oct; 22(10):1002-6. PubMed ID: 22953991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rationale of patients with early-stage papillary thyroid cancer for accepting or rejecting radioactive iodine remnant ablation.
    Sawka AM; Rilkoff H; Tsang RW; Brierley JD; Rotstein L; Ezzat S; Asa SL; Segal P; Kelly C; Zahedi A; Gafni A; Goldstein DP
    Thyroid; 2013 Feb; 23(2):246-7. PubMed ID: 23009127
    [No Abstract]   [Full Text] [Related]  

  • 20. Thyroid ablation with 1.1 GBq (30 mCi) iodine-131 in patients with papillary thyroid carcinoma at intermediate risk for recurrence.
    Rosário PW; Calsolari MR
    Thyroid; 2014 May; 24(5):826-31. PubMed ID: 24283207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.